Executive Order 14370: Increasing Medical Marijuana and Cannabidiol Research

What the order contains

Section headings exactly as they appear in the official text.

• Sec. 1. Purpose and Policy
• Sec. 2. Rescheduling Medical Marijuana and Improving Access to Cannabidiol Products
• Sec. 3. General Provisions

Section 1, quoted from the order

Verbatim text from the signed document. These are the words of the document, not SaveYourState’s.

Americans deserve access to the best medical treatments and research infrastructure in the world. In 2023, the Food and Drug Administration (FDA) completed a review of the landscape of medical use of marijuana and found scientific support for its use to treat anorexia related to a medical condition, nausea and vomiting, and pain. Chronic pain affects nearly 1 in 4 United States adults and more than 1 in 3 United States seniors, and 6 in 10 people who use medical marijuana report doing so to manage pain. Forty States plus the District of Columbia have State- or locally-sanctioned, regulated medical marijuana programs. Yet decades of Federal drug control policy have neglected marijuana's medical uses. That oversight has limited the ability of scientists and manufacturers to complete the necessary research on safety and efficacy to inform doctors and patients. […]